This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhang, D. Articles by Pizzorno, G. Search for Related Content PubMed PubMed Citation Articles by Zhang, D. Articles by Pizzorno, G.

p53-dependent Suppression of Uridine Phosphorylase Gene Expression through Direct Promoter Interaction¹

Departments of Internal Medicine (Oncology) and Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06520

Uridine phosphorylase (UPase) is a key enzyme in the pyrimidine salvage pathway. It reversibly catalyzes the catabolism of uridine to uracil; controls the homeostatic regulation of uridine concentration in plasma and tissues; and plays a role in the intracellular activation of 5-fluorouracil. We cloned the murine UPase gene promoter, a 1703-bp fragment, and determined the transcription initiation sites located at +1 and +92 bp of the cDNA sequence. Through transient expression analysis of the 5'-flanking region of UPase gene, we have evaluated the promoter activity for a series of fragments with 5'- to 3'-deletion in murine breast cancer EMT-6 cells and immortalized murine fibroblast NIH 3T3 cells. Cotransfection of the UPase promoter constructs (from -1619 to -445) containing p53 binding motif with the wild-type p53 construct resulted in a significant reduction of luciferase activity; however, this effect disappeared with the additional deletion of the -445 to -274 sequence to suggest the existence in this promoter region of a putative p53 recognition element. Similar cotransfection in murine embryo fibroblasts p53-/- confirmed the inhibitory role of p53 on the UPase promoter activity. The specificity of the interaction is demonstrated by nuclear protein-specific binding to the putative p53 recognition sequence using gel mobility shift assay and DNase I footprinting analysis. These data indicate the UPase gene is a novel target of p53, and its expression is down-regulated by p53 at the promoter level.

This article has been cited by other articles:

				X. Kong, H. Fan, X. Liu, R. Wang, J. Liang, N. Gupta, Y. Chen, F. Fang, and Y. Chang Peroxisome Proliferator-Activated Receptor {gamma} Coactivator-1{alpha} Enhances Antiproliferative Activity of 5'-Deoxy-5-Fluorouridine in Cancer Cells through Induction of Uridine Phosphorylase Mol. Pharmacol., October 1, 2009; 76(4): 854 - 860. [Abstract] [Full Text] [PDF]

				Z. Shi, Z. Cai, S. Wen, C. Chen, C. Gendron, A. Sanchez, K. Patterson, S. Fu, J. Yang, D. Wildman, et al. Transcriptional Regulation of the Novel Toll-like Receptor Tlr13 J. Biol. Chem., July 31, 2009; 284(31): 20540 - 20547. [Abstract] [Full Text] [PDF]

				L. Wan, D. Cao, J. Zeng, R. Yan, and G. Pizzorno Modulation of Uridine Phosphorylase Gene Expression by Tumor Necrosis Factor-{alpha} Enhances the Antiproliferative Activity of the Capecitabine Intermediate 5'-Deoxy-5-fluorouridine in Breast Cancer Cells Mol. Pharmacol., April 1, 2006; 69(4): 1389 - 1395. [Abstract] [Full Text] [PDF]